Search

everythinglearnresearchcommunity

for

Search:↓

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Key genes are crucial for Drosophila wing development and could be insecticide targets.

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Prolactin slows down hair growth in mice.

Certain drugs that block specific enzymes can help treat prostate diseases.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Hair follicle regeneration possible, more research needed.

A blood pressure drug, diltiazem, may also help treat influenza.